OrthoPediatrics Corp expected to post a loss of 28 cents a share - Earnings Preview

Orthopediatrics

23/02/2024 21:08

* OrthoPediatrics Corp  KIDS.OQ   KIDS.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
26 for the period ending December 31 2023
    * The Warsaw Indiana Indiana-based  company is expected to
report
a 21.7% increase in revenue to $37.733 million from $30.99
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.The company's guidance on January 8
2024, for the period ended December 31, was for revenue of
$37.600 million.
    * ​LSEG's mean analyst estimate for OrthoPediatrics Corp is
for a
loss of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
OrthoPediatrics
Corp is $38.50​, above​ its last closing price of $28.34. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.23       -0.23      -0.20     Beat    10.3
 Jun. 30 2023  -0.20       -0.22      -0.13     Beat    39.9
 Mar. 31 2023  -0.37       -0.36      -0.30     Beat    17.8​
 Dec. 31 2022  -0.23       -0.25      -0.35     Missed  -38.4
 ​​Sep.        -0.20       -0.20      -0.07     Beat    65.7
 30 2022                                                
 Jun. 30 2022  -0.22       -0.21      -0.02     Beat    90.7​
 Mar. 31 2022  -0.38       -0.37      -0.47     Missed  -26.7
 Dec. 31 2021  -0.31       -0.30      0.00      Beat    100
 This summary was machine generated February 23 at 21:08 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)